RxDoctor Payments Data

Steven Schmidt, MD

Plastic and Reconstructive Surgery · Centerville, OHNPI 1306860002

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,529 of the $1,854 with a category attached, or 82.4%. 17 manufacturers reported payments, led by Integra Lifesciences Corporation at 32.1% of the total.

$1,854in general payments, 2019–2025

Across 64 payments — averaging $28.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integra Lifesciences Corporation$595
  • Mentor Worldwide LLC$502
  • Davol Inc.$162
  • AbbVie$131
  • Musculoskeletal Transplant Foundation Inc.$92
  • BD$68
  • plus $305 from 11 others
$551,756in research payments, 2019–2025

Across 967 payments — averaging $570.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Mentor Worldwide LLC$537K
  • Medical Device Business Services, Inc.$15K

What the payments were for

  • Food & beverage$1,52982%
  • Other$32618%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,854 in reported general payments places this provider in the 55th percentile of 78 plastic and reconstructive surgery providers in Ohio.

See all plastic and reconstructive surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$96,095
Medicare patients
134
Services billed
498

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Monohydrate56$515
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen38$372
Methocarbamol36$225
Ondansetron Hcl46$124
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen20$107

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Centerville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →